| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.066 | 0.02 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |